Novartis Beats Osteoporosis Drug Injury Suit

Law360, Los Angeles (February 19, 2013, 1:11 PM EST) -- A California federal judge on Friday tossed a woman's claims stemming from multidistrict litigation that Novartis Pharmaceuticals Corp.'s osteoporosis drugs Aredia and Zometa destroyed her jaw, ruling that three expert witnesses hadn't shown the drugs were responsible for her bone damage.

U.S. District Judge Susan Illston granted Novartis' motion to strike the expert testimony of plaintiff Linda Messick's three doctors asserting the osteoporosis medications had caused Messick's jaw to deteriorate, saying they hadn't used reliable scientific methods to make a definitive diagnosis and that her claims...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Messick et al v. Novartis Pharmaceuticals Corporation


Case Number

3:12-cv-00693

Court

California Northern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Susan Illston

Date Filed

February 12, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.